Halozyme Therapeutics shares owned by Ensign Peak Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Ensign Peak Advisors
from 13F filings
Historical chart of Ensign Peak Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Ensign Peak Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $1.7M | 43k | 40.68 |
| 2023-09-30 | $13M | 339k | 38.20 |
| 2023-06-30 | $12M | 339k | 36.07 |
| 2023-03-31 | $1.7M | 45k | 38.19 |
| 2022-12-31 | $2.5M | 43k | 56.90 |
| 2022-09-30 | $1.7M | 43k | 39.53 |
| 2022-06-30 | $1.9M | 43k | 44.00 |
| 2022-03-31 | $1.8M | 46k | 39.88 |
| 2021-12-31 | $1.9M | 46k | 40.21 |
| 2021-09-30 | $8.3M | 203k | 40.68 |
| 2021-06-30 | $7.0M | 153k | 45.41 |
| 2021-03-31 | $6.4M | 153k | 41.69 |
| 2020-12-31 | $6.1M | 142k | 42.71 |
| 2020-09-30 | $1.4M | 53k | 26.29 |
| 2020-06-30 | $239k | 8.9k | 26.78 |
| 2020-03-31 | $161k | 8.9k | 18.04 |
| 2019-12-31 | $316k | 18k | 17.71 |